A novel sirolimus liposomal formulation was beneficial for the treatment of signs and symptoms of moderate to severe dry eye disease, according to a study.
In his presentation at the virtual Association for Research in Vision and Ophthalmology meeting, Alejandro Navas, MD, PhD, said that current treatment options for severe cases of dry eye disease are limited.
“Owing to its powerful immunosuppressive effects, local application of sirolimus could potentially play a significant role in the treatment of immune-mediated ocular surface diseases,” he said.
Researchers conducted a